Last update 16 Dec 2025

TVAX-008

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
TVAX 008, TVAX008
Target
HBcrAg x L-HBsAg
Action
inhibitors, stimulants
Mechanism
HBcrAg inhibitors(HBcrAg inhibitors), L-HBsAg inhibitors(L-HBsAg inhibitors), Immunostimulants
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication
Hepatitis B, Chronic
Inactive Indication-
Originator Organization
Grand Theravac Life Science Nanjing Co. Ltd.Grand Theravac Life Science Nanjing Co. Ltd.
Active Organization
Grand Theravac Life Science Nanjing Co. Ltd.Grand Theravac Life Science Nanjing Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationBreakthrough Therapy (China)
Login to view timeline

Related

7
Clinical Trials associated with TVAX-008
NCT07179653
/ Active, not recruitingPhase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients
ChiCTR2500105590
/ RecruitingPhase 2IIT
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment of Chronic Hepatitis B
NCT07204236
/ Active, not recruitingEarly Phase 1
Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion
100 Clinical Results associated with TVAX-008
Login to view more data
100 Translational Medicine associated with TVAX-008
Login to view more data
100 Patents (Medical) associated with TVAX-008
Login to view more data
100 Deals associated with TVAX-008
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 3-
Grand Theravac Life Science Nanjing Co. Ltd.Grand Theravac Life Science Nanjing Co. Ltd.
31 Dec 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free